LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
9.29
-0.47 (-4.82%)
At close: Apr 28, 2026, 4:00 PM EDT
9.45
+0.16 (1.72%)
After-hours: Apr 28, 2026, 7:04 PM EDT
LENZ Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for LENZ Therapeutics stock have an average target of 44, with a low estimate of 26 and a high estimate of 67. The average target predicts an increase of 373.63% from the current stock price of 9.29.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for LENZ Therapeutics stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $56 → $48 | Strong Buy | Maintains | $56 → $48 | +416.68% | Apr 21, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $52 → $26 | Strong Buy | Maintains | $52 → $26 | +179.87% | Mar 26, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $35 → $29 | Strong Buy | Maintains | $35 → $29 | +212.16% | Mar 25, 2026 |
| Raymond James | Raymond James | Buy Reiterates $40 → $50 | Buy | Reiterates | $40 → $50 | +438.21% | Oct 20, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $51 → $67 | Buy | Maintains | $51 → $67 | +621.21% | Oct 10, 2025 |
Financial Forecast
Revenue This Year
28.71M
from 19.09M
Increased by 50.42%
Revenue Next Year
85.32M
from 28.71M
Increased by 197.16%
EPS This Year
-3.87
from -2.85
EPS Next Year
-2.69
from -3.87
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 45.9M | 139.2M | ||||||
| Avg | 28.7M | 85.3M | ||||||
| Low | 16.1M | 52.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 140.4% | 384.8% | ||||||
| Avg | 50.4% | 197.2% | ||||||
| Low | -15.8% | 81.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -2.81 | -0.64 | ||||||
| Avg | -3.87 | -2.69 | ||||||
| Low | -4.60 | -3.40 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.